Showing results (11-20 of 171) with videos related to
Sort By:
Pageof 18
Blood|January 22, 2013
Platelet activation and inhibition in polycythemia vera and essential thrombocythemiaCarlo Patrono, Bianca Rocca, Valerio De StefanoCardiovascular Research|January 23, 2021
The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosisLina Badimon, Gemma Vilahur, Bianca Rocca, et al.Clinical Therapeutics|December 4, 2014
Role of clinical pharmacology in the development of antiplatelet drugsCarlo PatronoNature Reviews. Cardiology|April 9, 2009
The P2Y12 receptor: no active metabolite, no partyCarlo PatronoJournal of the American College of Cardiology|July 4, 2015
The Multifaceted Clinical Readouts of Platelet Inhibition by Low-Dose AspirinCarlo PatronoBritish Journal of Clinical Pharmacology|June 19, 2016
Cardiovascular effects of cyclooxygenase-2 inhibitors: a mechanistic and clinical perspectiveCarlo PatronoEuropean Heart Journal|June 5, 2024
Low-dose aspirin for the prevention of atherosclerotic cardiovascular diseaseCarlo PatronoThe Journal of Pharmacology and Experimental Therapeutics|June 6, 2023
Cyclooxygenase Inhibitors and Cancer: The Missing PiecesCarlo PatronoThe Journal of Pharmacology and Experimental Therapeutics|November 10, 2010
Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptorsGiovanna Petrucci, Raimondo De Cristofaro, Sergio Rutella, et al.Pageof 18